Long-term results (>25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high-grade, operable osteosarcoma

Cancer

Volumn 118, Issue 23, 2012, Pages 5888-5893

  Bernthal, Nicholas M ^a   Federman, Noah ^b   Eilber, Frederick R ^a   Nelson, Scott D ^a   Eckardt, Jeffrey J ^a   Eilber, Fritz C ^a   Tap, William D ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

chemotherapy; long term follow up; osteosarcoma; randomized trial

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; METHOTREXATE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OSTEOSARCOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCHOOL CHILD; SURVIVAL TIME; TUMOR NECROSIS;

ADOLESCENT; ADULT; BONE NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NECROSIS; OSTEOSARCOMA; PROSPECTIVE STUDIES;

EID: 84869491872     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27651     Document Type: Article

References (16)

1. Friedman MA, Carter SK,. The therapy of osteogenic sarcoma: current status and thoughts for the future. J Surg Oncol. 1972; 4: 482-510.
2. Fuchs N, Bielack SS, Epler D, et al. Long-term results of the co-operative German-Austrian-Swiss Osteosarcoma Study Group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol. 1998; 9: 893-899. (Pubitemid 28440449)
3. Eilber F, Giuliano A, Eckardt J, Patterson K, Moseley S, Goodnight J,. Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial. J Clin Oncol. 1987; 5: 21-26. (Pubitemid 17007852)
4. Rosen G, Marcove RC, Huvos AG, et al. Primary osteogenic sarcoma: 8-year experience with adjuvant chemotherapy. J Cancer Res. Clin Oncol. 1983; 106 (suppl): 55-67. (Pubitemid 13040824)
5. Wunder JS, Paulian G, Huvos AG, Heller G, Meyers PA, Healey JH,. The histological response to chemotherapy as a predictor of the oncological outcome of operative treatment of Ewing sarcoma. J Bone Joint Surg Am. 1998; 80: 1020-1033. (Pubitemid 28355673)
6. Huvos AG,. Bone Tumors: Diagnosis, Treatment, and Prognosis. 2nd ed. Philadelphia, PA: WB Saunders Company; 1991.
7. Link MP, Goorin AM, Miser AW, et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med. 1986; 314: 1600-1606. (Pubitemid 16118216)
8. Berend KR, Pietrobon R, Moore JO, Dibernardo L, Harrelson JM, Scully SP,. Adjuvant chemotherapy for osteosarcoma may not increase survival after neoadjuvant chemotherapy and surgical resection. J Surg Oncol. 2001; 78: 162-170. (Pubitemid 33021077)
9. Welck MJ, Gikas PD, Pearce P, Bhumbra R, Briggs TW, Cannon S,. Local recurrence of osteosarcoma after 17 years. Ann R Coll Surg Engl. 2009; 91: W17-W19.
10. Nagarajan R, Kamruzzaman A, Ness KK, et al. Twenty years of follow-up of survivors of childhood osteosarcoma: a report from the Childhood Cancer Survivor Study. Cancer. 2011; 117: 625-634.
11. Janeway KA, Grier HE,. Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects. Lancet Oncol. 2010; 11: 670-678.
12. Goorin AM, Schwartzentruber DJ, Devidas M, et al. Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. J Clin Oncol. 2003; 21: 1574-1580. (Pubitemid 46594112)
13. Benz MR, Tchekmedyian N, Eilber FC, Federman N, Czernin J, Tap WD,. Utilization of positron emission tomography in the management of patients with sarcoma. Curr Opin Oncol. 2009; 21: 345-351.
14. Souhami RL, Craft AW, Van der Eijken JW, et al. Randomised trial of 2 regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup. Lancet. 1997; 350: 911-917. (Pubitemid 27420527)
15. Link MP,. The multi-institutional osteosarcoma study: an update. Cancer Treat Res. 1993; 62: 261-267.
16. Eilber FC, Rosen G, Eckardt J, et al. Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas. J Clin Oncol. 2001; 19: 3203-3209. (Pubitemid 32591437)